This book aims to present, educate and inform individuals about Alzheimer's disease in a comprehensive manner. Its scope ranges from the discovery of the disease, epidemiology and basic biological principles underlying it, to advanced stem cell therapies used in the treatment of Alzheimer's. It adopts a 'global' perspective on Alzheimer's disease, and include epidemiological data and science from countries around the world.Alzheimer's disease is a rapidly growing problem seen in every country around the world. This is the first and only comprehensive book to cover Alzheimer's disease, and includes the most updated literature and scientific progress in the field of dementia and Alzheimer's disease research.Most books on the market that focus on Alzheimer's disease are targeted at caregivers as practical advice on how to deal with loved ones with the disease. This book instead is a comprehensive and popular science book that can be read by anyone with an interest in learning more about the disease.Dr Jefferson Chen MD, PhD, co-author, participated in the world's first surgical clinical trial using shunts to treat Alzheimer's disease. His first-hand involvement in a clinical trial for patients with Alzheimer's disease and experience treating Normal Pressure Hydrocephalus (NPH) which is commonly misdiagnosed as Alzheimer's disease lends a unique perspective.This book with appeal to a wide audience, regardless of their scientific or educational background.

Alzheimer's disease is a rapidly growing problem seen in every country around the world. This is the first and only comprehensive book to cover Alzheimer's disease, and includes the most updated literature and scientific progress in the field of dementia and Alzheimer's disease research.

This book aims to present, educate and inform individuals about Alzheimer's disease in a comprehensive manner. Its scope ranges from the discovery of the disease, epidemiology and basic biological principles underlying it, to advanced stem cell therapies used in the treatment of Alzheimer's. It adopts a "global" perspective on Alzheimer's disease, and include epidemiological data and science from countries around the world. Alzheimer's disease is a rapidly growing problem seen in every country around the world. This is the first and only comprehensive book to cover Alzheimer's disease, and includes the most updated literature and scientific progress in the field of dementia and Alzheimer's disease research. Most books on the market that focus on Alzheimer's disease are targeted at caregivers as practical advice on how to deal with loved ones with the disease. This book instead is a comprehensive and popular science book that can be read by anyone with an interest in learning more about the disease. Dr Jefferson Chen MD, PhD, co-author, participated in the world's first surgical clinical trial using shunts to treat Alzheimer's disease. His first-hand involvement in a clinical trial for patients with Alzheimer's disease and experience treating Normal Pressure Hydrocephalus (NPH) which is commonly misdiagnosed as Alzheimer's disease lends a unique perspective. This book with appeal to a wide audience, regardless of their scientific or educational background.

This book is a collection of outstanding research papers presented at the World Conference on Artificial Intelligence: Advances and Applications (WCAIAA 2023), organized by Sir Padampat Singhania University, India and is technically sponsored by Soft Computing Research Society during March 18–19, 2023. The topics covered are agent-based systems, evolutionary algorithms, approximate reasoning, bioinformatics and computational biology, artificial intelligence in modeling and simulation, natural language processing, brain-machine interfaces, collective intelligence, computer vision and speech understanding, data mining, swarm intelligence, machine learning, human-computer interaction, intelligent sensor, devices and applications, and intelligent database systems.

This book provides key critical tools to significantly broaden the readers’ perception of theatre and performance history: in line with posthuman thought, each chapter engages Actor-Network Theory and similar theories to reveal a comprehensive range of human and non-human agents whose collaborations impact theatre productions but are often overlooked. The volume also greatly expands the information available in English on the networks created by several Argentine artists. Through a transnational, transatlantic perspective, case studies refer to the lives, theatre companies, staged productions, and visual artworks of a number of artists who left Buenos Aires during the 1960s due to a mix of personal and political reasons. By establishing themselves in the French capital, queer playwright Copi and directors Jorge Lavelli, Alfredo Arias, and Jérôme Savary, among others, became part of the larger group of intellectuals known as “the Argentines of Paris” and dominated the Parisian theatre scene between the 1980s and 90s. Focusing on these Argentine artists and their nomadic peripeteias, the study thus offers a detailed description of the complexity of agencies and assemblages inextricably involved in theatre productions, including larger historical events, everyday objects, sexual orientation, microbes, and even those agents at work well before a production is conceived.